-
oa Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
- Source: Current Vascular Pharmacology, Volume 14, Issue 6, Nov 2016, p. 494 - 497
-
- 01 Nov 2016
Preview this article:




Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cvp/14/6/s2-1.gif
There is no abstract available.
© Bentham Science Publishers